about
Aromatase inhibitors for the treatment of endometriosisAromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.Role of estrogen receptor-β in endometriosisThe progressive simplification of the infertility evaluation.Altered retinoid uptake and action contributes to cell survival in endometriosis.Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis.Comparing thaw survival, implantation and live birth rates from cryopreserved zygotes, embryos and blastocysts.Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action.Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanismsActivated glucocorticoid and eicosanoid pathways in endometriosis.Steroidogenic factor-1 and endometriosis.Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.Metabolic syndrome and oocyte quality.Aneuploidy rates in failed pregnancies following assisted reproductive technology.Endometriosis: an update on management.Fruitful progress to fertility: preserving oocytes from chemodestruction.Correlation between depression, anxiety, and nausea and vomiting during pregnancy in an in vitro fertilization population: a pilot study.Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteinsSeptate uterus with cervical duplication and a longitudinal vaginal septum: a müllerian anomaly without a classificationOvarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population
P50
Q27010275-F4FB2151-3088-4874-87B2-8D16903E9C30Q30543147-545CCEF7-246A-49C7-9F47-4E18A22BF756Q33667641-DB0E9A25-9CBC-40A5-A5F8-3919E6A2238AQ34179873-1627F801-A6EA-490E-A4C9-BB083554B724Q34262490-D8D502A2-2144-4353-8413-97C751A1FE38Q34775795-94A7E5CC-020A-4942-A636-55BC0BD2D407Q35104492-8EC6BF66-9146-41A7-A5DA-0066BA530F3BQ35108292-8D682214-67A5-4A54-AEBA-295240742329Q35654201-8C423D2A-0F8D-4550-83F4-DD34FE40E47BQ35880096-9C69B942-EF99-41D6-9A1B-41C0EB12730AQ36074787-48633B25-4476-46B5-B17C-871BF9424B69Q37371164-02011770-524F-4EB4-9BFE-995D424E804EQ37417453-A8F115A0-6798-4C39-8832-8B4E98C64FFBQ37833348-EB8B5CB5-DAED-42A5-9C2D-A99B69A2D2F1Q37898131-BB330726-03A8-4E8A-8692-67CF70D9D051Q38103587-BAB61B41-5810-416C-9498-0BB5A7E0DA4FQ48659708-760A3325-537A-473E-8208-E0B54BAE96ABQ48869263-9C881C8D-FE5B-424A-96B1-3DE3B08AF755Q77452219-E5757B18-52CE-4CC4-A535-B1A87C756CC0Q83088245-461798C2-A236-4317-B8D9-D1823FEBEB18Q91903918-675DA749-34D4-4098-8628-D25824DE6C32
P50
description
researcher ORCID ID = 0000-0001-9682-6381
@en
name
Mary Ellen Pavone
@ast
Mary Ellen Pavone
@en
Mary Ellen Pavone
@es
Mary Ellen Pavone
@nl
type
label
Mary Ellen Pavone
@ast
Mary Ellen Pavone
@en
Mary Ellen Pavone
@es
Mary Ellen Pavone
@nl
prefLabel
Mary Ellen Pavone
@ast
Mary Ellen Pavone
@en
Mary Ellen Pavone
@es
Mary Ellen Pavone
@nl
P1153
12139054300
P31
P496
0000-0001-9682-6381